* NextGen Healthcare Inc NXGN.OQ NXGN.O is expected
to show a
rise in quarterly revenue when it reports results on January
24.
* The Atlanta Georgia-based company is expected to report
a
8.2% increase in revenue to $162.001 million from $149.72
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for NextGen Healthcare
Inc is
for earnings of 27 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for NextGen
Healthcare Inc is $20, above its last closing price of $17.30.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.23 0.23 0.25 Beat 9.5
Jun. 30 2022 0.16 0.16 0.16 Met 2.6
Mar. 31 2022 0.19 0.19 0.19 Met -2.2
Dec. 31 2021 0.20 0.21 0.24 Beat 15.2
Sep. 0.24 0.23 0.29 Beat 26.1
30 2021
Jun. 30 2021 0.21 0.21 0.25 Beat 20.3
Mar. 31 2021 0.19 0.19 0.21 Beat 8.8
Dec. 31 2020 0.24 0.25 0.26 Beat 5.4
This summary was machine generated January 20 at 22:11 GMT. All
figures in US dollars unless otherwise stated